nitter - Mulle kybernetiK

INVESTOR RELATIONS Fluicell - Fluicell

As an instrument company, sales is a major driver of growth for Fluicell.The year that passed brought many challenges for advancing sales but was also a year where Fluicell greatly expanded its presence on important markets and where the company increased its revenues by 88 per cent despite the pandemic. We are very excited to announce that Fluicell will be releasing its next product, Biozone 6 ™, during Q1 2021. Biozone 6 ™ is a new concept in high-resolution single-cell pharmacology. The product has been developed in connection with Hoffmann-La Roche and has been tailored to meet the demand for research tools for single-cell pharmacology. Microfluidic Technologies for Life Science.

Fluicell news

Fluicell is off to a promising start in 2020. This much was clear in the Q1 report released by the Swedish single-cell technology company two weeks ago. The sales numbers are indicative of a strong first quarter for Fluicell with further expansion on the horizon, mainly thanks to the broad range of innovative products that the company already has on the market and its newly established CRO But as . Fluicell has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Köp aktien Fluicell AB (FLUI). Hos Nordnet kan du handla från 0 kr i courtage.

News zur FLUICELL AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ Fluicell launches Biozone 6.

SwedNanoTech LinkedIn

Fluicell är ett svenskt bolag i life science-sektorn som säljer och utvecklar instrument för bioprinting, läkemedelscreening och farmakologi. Bolaget utveckl Fluicell, Mölndal.

Fluicell AB - IPOhub

Fluicell är ett teknikbolag. Specialisering sker inom bearbetning och studering av cellers sammansättning vid läkemedelsutvecklingar. Bolaget har framtagit en produktportfölj bestående av patenterade forskningsinstrument, som används för att studera, analysera och slutligen bearbeta celler. Fluicell will be showing how 3D single-cell bioprinting can take in vitro models to the next level. Looking forward to a more sustainable research environment. Overall, with the continuously rising drug development costs, and with the long times required to take a new drug to the market, the need for a new experimental system cannot be overstated.

Fluicell · Order Depth Real time 15 min delayed · Trades Real time 15 min delayed · Indexes · Company News · Warrantlist · Options & futures FLUICELL AB share price in real-time (A2JG86 / SE0010831321), charts and analyses, news, key data, turnovers, company data. Fluicell launches Biozone 6.
Vädret vårgårda

Dec 22, 2020 H2020,BIRDIE,FETOPEN-01-2018-2019-2020,UNIVERSITEIT MAASTRICHT(NL ),FLUICELL AB(SE),UNIVERSITE DE NANTES(FR),TISSUSE News agencies, without understanding the essence of the message, spread the Fluicell, a Swedish biotech company, specializes in development of platforms Tatsiana LOBOVKINA, CSO | Cited by 1777 | of Fluicell, Göteborg | Read 33 publications | Contact Tatsiana LOBOVKINA. Fluicell är ett Göteborgsbaserat bolag som har kommersialiserat en Fluicells befintliga produkter är forskningsinstrumenten BioPen®,Dynaflow® Resolve och För ett bolag som Fluicell, som fokuserar på medicinska instrument, är försäljning en viktig faktor för tillväxt. Året som gick innebar många The Biopixlar was without a doubt a big newsmaker for Fluicell during 2020, which is no surprise considering its potential as an R&D tool.

The sales numbers are indicative of a strong first quarter for Fluicell with further expansion on the horizon, mainly thanks to the broad range of innovative products that the company already has on the market and its newly established CRO We are very excited to announce that Fluicell will be releasing its next product, Biozone 6™, during Q1 2021. Biozone 6™ is a new concept in high-resolution single-cell pharmacology. The product has been developed in connection with Hoffmann-La Roche and has been tailored to meet the demand for research tools for single-cell pharmacology.
Skolplatsen bollnäs

likvidation av bostadsrattsforening
h&m arbetsförhållanden
ink4
butikschef lön systembolaget
jobb östergötland miljö
lastvikter lastbil och släp
pa utbildning linköping